RESUMEN
OBJECTIVES: To assess whether preterm infants with postnatal cytomegalovirus infection develop neurologic sequelae in early childhood. METHODS: Infants <32 weeks' gestation were prospectively screened for cytomegalovirus (CMV) at term-equivalent age. Neurodevelopment was compared between CMV-positive and CMV-negative infants by using the Griffiths Mental Development Scales (GMDS) at 16 months' corrected age (CA); the Bayley Scales of Infant and Toddler Development, Third Edition or the GMDS at 24 to 30 months' CA; and the Wechsler Preschool and Primary Scale of Intelligence, Third Edition and Movement Assessment Battery for Children, Second Edition at 6 years of age. At 6 years old, hearing was assessed in CMV-positive children. RESULTS: Neurodevelopment was assessed in 356 infants at 16 months' CA, of whom 49 (14%) were infected and 307 (86%) were noninfected. Infected infants performed significantly better on the GMDS locomotor scale. There were no differences at 24 to 30 months' CA on the Bayley Scales of Infant and Toddler Development, Third Edition or GMDS. At 6 years of age, infected children scored lower on the Wechsler Preschool and Primary Scale of Intelligence, Third Edition, but mean scores were within normal range, reaching significance only in verbal IQ (96 [SD 17] vs 103 [SD 15] points; P = .046). Multiple regression indicated no impact of CMV status but significant influence of maternal education and ethnicity on verbal IQ. No significant differences in motor development were found and none of the infected children developed sensorineural hearing loss. CONCLUSIONS: In this cohort study, postnatal cytomegalovirus infection in preterm children did not have an adverse effect on neurodevelopment within the first 6 years of life.
Asunto(s)
Desarrollo Infantil , Infecciones por Citomegalovirus/complicaciones , Enfermedades del Prematuro , Niño , Preescolar , Estudios de Cohortes , Discapacidades del Desarrollo/etiología , Pérdida Auditiva/etiología , Humanos , Recién Nacido , Recien Nacido Prematuro , Pruebas de InteligenciaRESUMEN
OBJECTIVE: Assessment of the clinical effectiveness of bilateral cochlear implantation compared with unilateral cochlear implantation or bimodal stimulation, in adults with severe-to-profound hearing loss. In 2007, the National Institute for Health and Clinical Excellence (NICE) in the U.K. conducted a systematic review on cochlear implantation. This study forms an update of the adult part of the NICE review. DATA SOURCES: The electronic databases MEDLINE and Embase were searched for English language studies published between October 2006 and March 2011. STUDY SELECTION: Studies were included that compared bilateral cochlear implantation with unilateral cochlear implantation and/or with bimodal stimulation, in adults with severe-to-profound sensorineural hearing loss. Speech perception in quiet and in noise, sound localization and lateralization, speech production, health-related quality of life, and functional outcomes were analyzed. DATA EXTRACTION: Data extraction forms were used to describe study characteristics and the level of evidence. DATA SYNTHESIS: The effect size was calculated to compare different outcome measures. CONCLUSION: Pooling of data was not possible because of the heterogeneity of the studies. As in the NICE review, the level of evidence of the included studies was low, although some of the additional studies showed less risk of bias. All studies showed a significant bilateral benefit in localization over unilateral cochlear implantation. Bilateral cochlear implants were beneficial for speech perception in noise under certain conditions and several self-reported measures. Most speech perception in quiet outcomes did not show a bilateral benefit. The current review provides additional evidence in favor of bilateral cochlear implantation, even in complex listening situations.
Asunto(s)
Implantes Cocleares , Sordera/rehabilitación , Adulto , Algoritmos , Niño , Medicina Basada en la Evidencia , Lateralidad Funcional/fisiología , Humanos , Ruido , Sesgo de Publicación , Ensayos Clínicos Controlados Aleatorios como Asunto , Proyectos de Investigación , Percepción del Habla , Resultado del TratamientoRESUMEN
OBJECTIVE: To assess the clinical effectiveness of bilateral cochlear implantation compared with unilateral cochlear implantation alone or with a contralateral hearing aid (bimodal stimulation), in children with severe-to-profound hearing loss. Recently, the National Institute for Health and Clinical Excellence (NICE) in the U.K. has conducted a systematic review on cochlear implantation. We decided to update the pediatric part of the NICE review. DATA SOURCES: The electronic databases MEDLINE and Embase were searched for European, North American, and Australasian studies published between October 2006 and June 2009. Reference lists of the included articles were also searched for relevant articles. STUDY SELECTION: Studies were included if they comprised data on comparisons between bilateral cochlear implantation and unilateral cochlear implantation and/or bilateral cochlear implantation and bimodal stimulation, in children with severe-to-profound sensorineural hearing loss. The following outcome measures were analyzed: audiological, speech perception, speech production, functional capacities, health-related quality of life, and/or educational outcomes. DATA EXTRACTION: Characteristics of the participants, interventions, outcomes, and methodological comments were entered into data extraction forms and the level of evidence was assessed. DATA SYNTHESIS: Results were standardized for each outcome measure by calculating a standardized mean difference (effect size). CONCLUSION: Effect sizes could not be pooled because of the heterogeneity of the studies. Therefore, we presented the results qualitatively. Although the level of evidence was low, the advantages of bilateral cochlear implants corresponded with the primary benefits of bilateral hearing, that is, improved speech perception in quiet and noise. Localization results were less consistent. No data on audiologic, speech production, or educational outcomes were available.
Asunto(s)
Implantes Cocleares , Sordera/terapia , Algoritmos , Audiometría de Tonos Puros , Niño , Implantación Coclear , Interpretación Estadística de Datos , Educación , Pérdida Auditiva Bilateral/terapia , Humanos , Variaciones Dependientes del Observador , Calidad de Vida , Proyectos de Investigación , Habla , Percepción del Habla , Resultado del TratamientoRESUMEN
OBJECTIVE: To assess if hearing loss is a feature of Joubert syndrome (JBS), one of the ciliopathies and therefore possibly associated with hearing loss. DESIGN: Retrospective case series. SETTING: University Children's Hospital. PATIENTS: Dutch patients with JBS. MAIN OUTCOME MEASURES: Audiological data. RESULTS: Data from 22 Dutch Joubert syndrome (JBS) cases (17 males, 5 females) aged 3-40 years were available. Audiological tests were successfully performed in 14 cases. Three cases (aged 17-26 years) showed very mild sensorineural hearing loss (SNHL) at different frequencies. Conductive hearing loss due to middle ear infections occurred frequently in young JBS children (6 out of 22 cases). In three cases (aged 3-13 years) the parents reported the child was hypersensitive to sound. CONCLUSION: We found no evidence for significant hearing loss in Joubert syndrome patients. However, given the compromised speech development in JBS, conductive hearing loss due to middle ear infections should be treated vigorously. SNHL at a later age cannot be excluded on the basis of our data, given the sample size. Three of the older cases showed discretely increased hearing thresholds. Analogous to the ciliopathy Bardet-Biedl syndrome, where hearing thresholds were reported to be subclinically increased in a group of adolescents patients, we recommend follow-up of JBS patients in view of the possibility of progressive, late-onset SNHL.
Asunto(s)
Trastornos de la Motilidad Ciliar/complicaciones , Discapacidades del Desarrollo/complicaciones , Pérdida Auditiva Conductiva/complicaciones , Pérdida Auditiva Sensorineural/complicaciones , Adolescente , Adulto , Audiometría de Tonos Puros , Cerebelo/anomalías , Niño , Preescolar , Trastornos de la Motilidad Ciliar/genética , Discapacidades del Desarrollo/genética , Potenciales Evocados Auditivos del Tronco Encefálico , Femenino , Pérdida Auditiva Conductiva/diagnóstico , Pérdida Auditiva Sensorineural/diagnóstico , Humanos , Masculino , Otitis Media/complicaciones , Síndrome , Adulto JovenRESUMEN
Haploinsufficiency of the zinc finger transcription factor GATA3 causes the triad of hypoparathyroidism, deafness and renal dysplasia, known by its acronym HDR syndrome. The purpose of the current study was to describe in detail the auditory phenotype in human HDR patients and compare these to audiometrical and histological data previously described in a mouse model of this disease. Pure tone audiometry, speech audiometry, speech in noise, auditory brainstem responses and transiently evoked otoacoustic emissions were measured in 2 patients affected by HDR syndrome. Both patients were affected by a moderate-to-severe sensorineural hearing loss. Speech reception thresholds were shifted and speech recognition in noise was disturbed. No otoacoustic emissions could be generated in either patient. Auditory brainstem response interpeak intervals were normal. The human and murine audiological phenotypes seem to correspond well. Hearing loss in HDR syndrome is moderate to severe, seems to be slightly worse at the higher end of the frequency spectrum and may be progressive with age. The absence of otoacoustic emissions and the loss of frequency selectivity suggest an important role for outer hair cells in causing the hearing loss.
Asunto(s)
Umbral Auditivo/fisiología , Pérdida Auditiva Sensorineural/fisiopatología , Hipoparatiroidismo/fisiopatología , Riñón Displástico Multiquístico/fisiopatología , Adulto , Audiometría de Tonos Puros , Audiometría del Habla , Potenciales Evocados Auditivos del Tronco Encefálico/fisiología , Femenino , Factor de Transcripción GATA3/deficiencia , Factor de Transcripción GATA3/genética , Pérdida Auditiva Sensorineural/genética , Humanos , Hipoparatiroidismo/genética , Masculino , Riñón Displástico Multiquístico/genética , Ruido , Emisiones Otoacústicas Espontáneas/fisiología , Fenotipo , SíndromeRESUMEN
Anesthesia is known to affect the auditory brainstem response (ABR) in animals often used in hearing research. This study describes the differences in ABRs between awake and anesthetized FVB/N mice. Intracranial electrodes connected to a head fixation pedestal were used for click-evoked ABR recordings. This pedestal served to immobilize mice, either awake or under anesthesia, in a 'free' sound field. The presence of myogenic noise in the awake condition obviously increases recording time. However it is demonstrated that recording times can be significantly reduced by increasing the stimulus repetition rate from 23 up to 80 impulses per second. This causes only a small but significant increase in absolute peak latencies in the awake condition, but has no significant effect on the overall ABR-waveform, nor on the ABR-threshold, nor on the ABR interpeak latencies, nor on the absolute peak latencies in the anesthetized condition. Anesthesia with ketamine/xylazine caused a significant prolongation of ABR-peak latencies and interpeak latencies as well as a significant upward shift (8.0+/-1.8 dB) of ABR-thresholds as compared to the awake condition. Under anesthesia the measurement accuracy of peak latencies, interpeak latencies and thresholds decreases. In conclusion, the awake condition is preferable for more accurate measurements of ABR characteristics, in spite of the myogenic noise concomitant with this condition.
Asunto(s)
Anestesia , Anestésicos Disociativos , Potenciales Evocados Auditivos del Tronco Encefálico , Ketamina , Xilazina , Estimulación Acústica , Animales , Umbral Diferencial , Femenino , Masculino , Ratones , Ratones Endogámicos , Tiempo de ReacciónRESUMEN
Patients with HDR syndrome suffer from hypoparathyroidism, deafness, and renal dysplasia due to a heterozygous deletion of the transcription factor GATA3. Since GATA3 is prominently expressed in both the inner ear and different parts of the auditory nervous system, it is not clear whether the deafness in HDR patients is caused by peripheral and/or central deficits. Therefore, we have created and examined heterozygous Gata3 knockout mice. Auditory brainstem response (ABR) thresholds of alert heterozygous Gata3 mice, analyzed from 1 to 19 months of age, showed a hearing loss of 30 dB compared to wild-type littermates. Neither physiological nor morphological abnormalities were found in the brainstem, cerebral cortex, the outer or the middle ear. In contrast, cochleae of heterozygous Gata3 mice showed significant progressive morphological degeneration starting with the outer hair cells (OHCs) at the apex and ultimately affecting all hair cells and supporting cells in the entire cochlea. Together, these findings indicate that hearing loss following Gata3 haploinsufficiency is peripheral in origin and that this defect is detectable from early postnatal development and maintains through adulthood.